Skip to main content
Rural Health Information Hub

Rural Pharmacy and Prescription Drugs – News

News stories from the past 60 days.

Dec 13, 2024 - Notice of final rule from the U.S. Department of Health and Human Services (HHS) adopting updated versions of the retail pharmacy standards for electronic transactions adopted under the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). These updated versions are modifications to the currently adopted standards for the following retail pharmacy transactions: healthcare claims or equivalent encounter information; eligibility for a health plan; referral certification and authorization; and coordination of benefits. This final rule also adopts a modification to the standard for the Medicaid pharmacy subrogation transaction. This rule is effective February 11, 2025. Compliance with this rule is required by February 11, 2028.
Source: Federal Register
Dec 11, 2024 - Notice of amendment from the Department of Health and Human Services extending the determination of a public health emergency and states that COVID-19 presents a credible risk of a future public health emergency. Among other things, this amendment extends liability immunity for licensed pharmacists, pharmacy interns, and qualified pharmacy technicians to prescribe, dispense, and administer COVID-19 vaccines, seasonal influenza vaccines, and COVID-19 tests through December 31, 2029. This amendment is effective January 1, 2025.
Source: Federal Register
Dec 9, 2024 - Discusses anticipated challenges with receiving prescription medication for rural Missouri residents relying on the U.S. Postal Service due to planned changes to distribution routes and less frequent service. Notes there have been increases in mail-order prescriptions alongside a national trend in rural pharmacy closures.
Source: Missouri Independent
Dec 4, 2024 - Profiles a rural-based Tennessee pharmacy system, noting the rural health disparities that pharmacy access can help alleviate and the benefits of a community pharmacy.
Source: UTHSC News
Nov 19, 2024 - Notice from the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) issuing a temporary rule to extend certain exceptions to existing DEA regulations implemented in March 2020 because of the COVID-19 Public Health Emergency (COVID-19 PHE). The full set of telemedicine flexibilities regarding the prescription of controlled medications that were in place during the COVID-19 PHE as outlined in the Second Temporary Rule will remain in place through December 31, 2025. This rule is effective January 1, 2025, through December 31, 2025.
Source: Federal Register
Oct 28, 2024 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on a new information collection request titled "Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) Information Collection Request." CMS will collect information from manufacturers of Medicare Part D drugs selected for negotiation under the Inflation Reduction Act for the initial price applicability years 2026 and 2027 and the dispensing entities that dispense the selected drugs to maximum fair price (MPF)-eligible individuals. CMS will also use a Medicare Transaction Facilitator (MTF) to facilitate the effectuation of MPFs. Comments are due by December 27, 2024.
Source: Federal Register

Last Updated: 12/13/2024